Literature DB >> 16865634

Syncope of a drug addict - a special case.

Bidisha Chatterjee, Ulrich Bürgi.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16865634     DOI： 10.1007/s00392-006-0420-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.

Authors:  J Schrickel; H Bielik; A Yang; J O Schwab; N Shlevkov; R Schimpf; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2003-10

2.  Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels.

Authors:  Jiesheng Kang; Xiao Liang Chen; Hongge Wang; David Rampe
Journal:  Eur J Pharmacol       Date:  2003-01-01       Impact factor: 4.432

3.  Can methadone prolong the QT interval?

Authors:  J A Decerf; B Gressens; C Brohet; A Liolios; P Hantson
Journal:  Intensive Care Med       Date:  2004-06-08       Impact factor: 17.440

4.  Familial hypertrophic cardiomyopathy associated with prolongation of the QT interval.

Authors:  S Peters; H Rust; M Trümmel; A Brattström
Journal:  Z Kardiol       Date:  2000-07

5.  Torsade de pointes induced by ajmaline.

Authors:  W Haverkamp; G Mönnig; P Kirchhof; L Eckardt; M Borggrefe; G Breithardt
Journal:  Z Kardiol       Date:  2001-08

6.  QTc interval prolongation in patients on long-term methadone maintenance therapy.

Authors:  Icro Maremmani; Matteo Pacini; Claudio Cesaroni; Mercedes Lovrecic; Giulio Perugi; Alessandro Tagliamonte
Journal:  Eur Addict Res       Date:  2005       Impact factor: 3.015

7.  Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.

Authors:  P Milberg; N Reinsch; N Osada; K Wasmer; G Mönnig; J Stypmann; G Breithardt; W Haverkamp; L Eckardt
Journal:  Basic Res Cardiol       Date:  2005-06-10       Impact factor: 17.165

8.  QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.

Authors:  Merce Gil; Montserrat Sala; Ignasi Anguera; Olga Chapinal; Manuel Cervantes; Joan R Guma; Ferran Segura
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

9.  Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts.

Authors:  A Gerhardy; G Scholtysik; A Schaad; R Haltiner; T Hess
Journal:  Basic Res Cardiol       Date:  1998-08       Impact factor: 17.165

10.  Tridimensional activation patterns of acquired torsade-de-pointes tachycardias in dogs with chronic AV-block.

Authors:  Kirsten D Schreiner; Frederik Voss; Julia C Senges; Ruediger Becker; Patrizia Kraft; Alexander Bauer; Kamilla Kelemen; Wolfgang Kuebler; Marc A Vos; Wolfgang Schoels
Journal:  Basic Res Cardiol       Date:  2004-03-12       Impact factor: 17.165
  10 in total
  1 in total

1.  Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.

Authors:  Konstantinos P Letsas; Michalis Efremidis; Stavros P Kounas; Loukas K Pappas; Gerasimos Gavrielatos; Ioannis P Alexanian; Nikolaos P Dimopoulos; Gerasimos S Filippatos; Antonios Sideris; Fotis Kardaras
Journal:  Clin Res Cardiol       Date:  2008-11-24       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.